USPTO serial 79395707
ALGOTX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- EULIN, INGRID C
- Law office
- TMEG LAW OFFICE 105
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with ALGOTX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products; veterinary products; medical dressings; chemical preparations for medical use; chemical preparations for pharmaceutical use; pharmaceutical preparations; chemico-pharmaceutical products; pharmaceutical substances; chemical-pharmaceutical preparations; medicines; pharmaceutical solutions; diagnostic agents for medical use; chemical products for pharmaceutical use; chemical reagents for medical use; chemical reagents for veterinary use; chemical preparations for medical use; chemical preparations for pharmaceutical use; chemical analysis reagents for medical use; chemical analysis reagents for veterinary use; pharmaceuticals for the treatment of rare diseases; medicinal preparations and substances; veterinary products; veterinary preparations; biological tissue cultures for medical use; biological tissue cultures for veterinary use; biotechnological preparations for medical use; biochemical preparations for medical use; biochemical preparations for veterinary use; chemicals for hygiene for medical use; chemical diagnostic reagents for medical use; chemotherapeutic agents; pharmaceutical preparations for use in chemotherapy; crude medicines; tonics [medicines]; drug delivery agents; diagnostic agents for pharmaceutical use; analeptics (pharmaceuticals); compounds for pharmaceutical use; hygienic products for medical use; medicated preparations; dietetic foods for medical use; dietetic foodstuffs for veterinary use; sanitary products for medicine; disinfectant soaps; medicinal soaps; medicated shampoos; medicated dentifrices; food for babies; food supplements; nutritional supplements; dietary supplements for food; nutritional and dietetic preparations; disinfectants and antiseptics; hygienic preparations and articles; products for destroying vermin; fungicides; herbicides; bath preparations for medical use; medicinal herbs; medicinal herbal teas; parasiticides; natural medicines; medicinal health care preparations; nutraceutical products for humans; nutraceutical products for animals; medicinal drinks; dietetic beverages for medical use; vitamins in the form of beverages; dietetic foods for clinical nutrition. | ACTIVE | — |
| 042 | Scientific, technical and technological research; research and development of new products for third parties; technical project studies; scientific laboratory services; carrying out clinical trials for pharmaceutical products; provision of information concerning the results of clinical trials for pharmaceutical products; provision of information in connection with medical and scientific research in the field of pharmaceutical products and clinical trials; biological, clinical and medical research; clinical research; carrying out clinical trials; research in the field of medicines; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; research and development of pharmaceutical products; laboratory research services concerning pharmaceutical products; consultancy with respect to pharmaceutical research and development; consulting relating to pharmacology; consultancy in the field of pharmaceutical research; services for conducting early assessments of new pharmaceuticals; clinical testing services for third parties; providing a platform for developing medicines (platform as a service (PaaS)); clinical trials; Scientific research and laboratory research services in the field of biotechnology; biotechnical research; advice in the field of biotechnology; bacteriology research; biological research; research and development of new pharmaceutical products and components for third parties; chemical research and analysis services; research and development in the field of pharmaceuticals and biotechnology; biotechnological research; biotechnology testing services; preparation of reports with respect to biotechnology; information about scientific research in the field of biochemistry and biotechnology; design services of processing systems for the biotechnological industry; biochemical engineering services; biochemical analyses; consulting relating to biochemistry; biochemical research and development; consultancy services in the field of biochemistry; bio-organic chemical research; medicine discovery services; chemical technology research; pharmacological research services; writing of computer programs for biotechnological applications; development of measuring probes for biotechnological applications; quality control, authentication and testing. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 19, 2026 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 30, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 30, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 31, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 15, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 15, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 30, 2025 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 30, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 16, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 4, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 16, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 16, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 25, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 24, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 22, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 22, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 16, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |